Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

Why aren't there more physician 'extenders'?

R Chase

Texas Medicine

|December 1, 1992

Summary

No abstract available in PubMed .

Related Concept Videos

You might also read

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

MGIS: managing banana (Musa spp.) genetic resources information and high-throughput genotyping data.

Database : the journal of biological databases and curation·2017

Same author

Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.

Harm reduction journal·2017

Same author

Local partnerships for healthy workplaces and communities:.

New solutions : a journal of environmental and occupational health policy : NS·2012

Same author

Tick infestation and spotted-fever group Rickettsia in shelter dogs, California, 2009.

Zoonoses and public health·2011

Same author

Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 protease.

Antimicrobial agents and chemotherapy·2010

Same author

SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells.

Antimicrobial agents and chemotherapy·2006

Related Experiment Videos

Why aren't there more physician 'extenders'?

Related Concept Videos

Related Articles

MGIS: managing banana (Musa spp.) genetic resources information and high-throughput genotyping data.

Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.

Local partnerships for healthy workplaces and communities:.

Tick infestation and spotted-fever group Rickettsia in shelter dogs, California, 2009.

Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 protease.

SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells.